NMDA receptor mRNA correlation with antemortem cognitive impairment in schizophrenia

NeuroReport

Volumn 7, Issue 12, 1996, Pages 2051-2055

  Humphries, Clare ^a   Mortimer, Ann ^a   Hirsch, Steven ^a   De Belleroche, Jacqueline ^a  

^a IMPERIAL COLLEGE SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

cognitive function; gene expression; glutamate; NMDA receptor; NR 1 mRNA; schizophrenia; temporal cortex

Indexed keywords

GLUTAMATE RECEPTOR; MESSENGER RNA; N METHYL DEXTRO ASPARTIC ACID RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COGNITION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; SCHIZOPHRENIA; TEMPORAL CORTEX;

EID: 0029910263     PISSN: 09594965     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001756-199608120-00040     Document Type: Article

References (30)

1. Virgo L, Humphries C, Mortimer A et al. Biol Psychiat 37, 694-701 (1995).
2. Kim JS, Kornhuber HH, Schmid-Burgk W et al. Neurosci Lett 20, 379-382 (1980).
3. Deakin JFW, Slater P, Simpson MDC et al. J Neurochem 52, 1781-1786 (1989).
4. Kerwin R, Patel S and Meldrum B. Neuroscience 39, 28-32 (1990).
5. Kornhuber J, Mack-Burckhardt R, Riederer F et al. J Neural Transm 77, 231-236 (1989).
6. Eastwood SL, McDonald B, Burnet PWJ et al. Mol Brain Res 29, 211-223 (1995).
7. Foster P. Pharmaceutical J 30 Sept, 431-432 (1989).
8. Liddle PF. Br J Psychiat 151, 145-151 (1987).
9. Hyde CE. Br J Psychiat 155, 45-48 (1989).
10. Reisberg B, Ferris FH, De Leon MJ et al. Am J Psychiat 139, 1136-1139 (1982).
11. Folstein MF, Folstein FE and McHugh PR. J Psychiat Res 12, 189-198 (1975).
12. Nelson HE. The National Adult Reading Scale (NART) Test Manual. Windsor: NFER-Nelson, 1982.
13. Ammons RB and Ammons CH. Psychological Rep 11, 111-161 (1962).
14. Wilson BA, Cockburn J and Baddeley A. 4The Rivermead Behavioural Memory Test. Reading: Thames Valley Test Company, 1985.
15. Collins AM and Quillian MR. J Verbal Learn Verbal Behav 8, 240-247 (1969).
16. Parker DM and Crawford JR. In: Crawford JR, Parker DM and McKinlay WW, eds. A Handbook of Neuropsychological Assessment. Hove: Lawrence Erlbaum, 1992: 267-291.
17. Chomczynski P and Sacchi N. Anal Biochem 162, 156-159 (1987).
18. de Belleroche J, Bandopadhyay R, King A et al. Neuropeptides 15, 201-212 (1990).
19. Wood H and de Belleroche J. Brain Res 545, 183-190 (1991).
20. Virgo L and de Belleroche J. Brain Res 676, 196-204 (1995).
21. Karp SJ, Masu M, Eki T et al. J Biol Chem 268, 3728-3733 (1993).
22. King DJ. Br J Psychiatry 157, 799-811 (1990).
23. Aylwood E, Walker E and Bittes B. Schizophrenia Bull 10, 430-459 (1984).
24. Mortimer AM and McKenna PJ. Psychol Med 24, 541-545 (1994).
25. Nordberg A. Cerebrovasc Brain Metab Rev 4, 303-328 (1992).
26. EI-Mallakh RS, Kirch DG, Shelton R et al. J Neuropsychiatry 3, 383-385 (1991).
27. Purohit DP, Davidson M, Perl DP et al. Biol Psychiat 33, 255-260 (1993).
28. Arnold SE, Franz BR and Trojanowski JQ. Neurobiol Ageing 15, 299-303 (1994).
29. Jones RW, Wesnes KA and Kirby J. Ann NY Acad Sci 640, 241-244 (1991).
30. Javitt DC, Zylberman I, Zukin SR et al. Am J Psychiat 151, 1234-1236 (1994).